| Pharmaceutical active ingredients: |
| Dihydroergotamine Mesylate |
| Available forms, composition and doses of Morena: |
| N / A |
| Morena medical category: |
| Human:Antimigraine preparationsSympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA01 - Dihydroergotamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| 3M |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ikaran | Dihydroergotamine Mesylate | Pierre Fabre; Formenti Farmaceutici; Nycomed; Robapharm |
| Ikaran LP | Dihydroergotamine Mesylate | Pierre Fabre |
| Ikaran Retard | Dihydroergotamine Mesylate | Pierre Fabre; Robapharm |
| Migranal | Dihydroergotamine Mesylate | Novartis; Sterimax; Valeant Pharmaceuticals |
| Migranil Injections | Dihydroergotamine Mesylate | Inga Laboratories |
| Orstanorm | Dihydroergotamine Mesylate | Novartis |
| Pervone | Dihydroergotamine Mesylate | Sanofi-Aventis |
| Poligot | Dihydroergotamine Mesylate | Polipharm, Thailand |
| Seglor | Dihydroergotamine Mesylate | Schwarz Pharma; Pharmafair; Sanofi-Aventis |
| Seglor Lyoc | Dihydroergotamine Mesylate | Schwarz Pharma |